Magic mushroom therapy trial aims to help veterans battle depression and addiction
NCT ID NCT07499583
Summary
This study is testing whether a single dose of psilocybin (the active compound in 'magic mushrooms'), given alongside supportive psychotherapy, is safe and can help reduce symptoms of severe, treatment-resistant depression and substance use disorders. It will involve 50 veterans and first responders. Researchers will compare three different doses to see their effects on substance use and depression over six weeks, while also studying brain changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Goodman Hall, Dept of Psychiatry, Indiana University
Indianapolis, Indiana, 46202-3082, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
The Stark Neuroscience Building (Goodman Hall)
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.